Page 2273 - Williams Hematology ( PDFDrive )

2248 Part XII: Hemostasis and Thrombosis Chapter 131: The Antiphospholipid Syndrome 2249

135. Martinelli I, Cattaneo M, Panzeri D, et al: Risk factors for deep venous thrombosis of 168. Matsushita T, Kanda F, Yamada H, Chihara K: Recurrent acute transverse myelopathy:
the upper extremities. Ann Intern Med 126:707–711, 1997. An 83-year-old man with antiphospholipid syndrome. Rinsho Shinkeigaku 37:987–991,
136. Provenzale JM, Ortel TL, Allen NB: Systemic thrombosis in patients with antiphos- 1997.
pholipid antibodies: Lesion distribution and imaging findings. AJR Am J Roentgenol 169. Ruiz AG, Guzman RJ, Flores FJ, Garay MJ: Refractory hiccough heralding transverse
170:285–290, 1998. myelitis in the primary antiphospholipid syndrome. Lupus 7:49–50, 1998.
137. Poux JM, Boudet R, Lacroix P, et al: Renal infarction and thrombosis of the infrarenal 170. Takamura Y, Morimoto S, Tanooka A, Yoshikawa J: Transverse myelitis in a patient with
aorta in a 35-year-old man with primary antiphospholipid syndrome. Am J Kidney Dis primary antiphospholipid syndrome—A case report. No To Shinkei 48:851–855, 1996.
27:721–725, 1996. 171. Campi A, Filippi M, Comi G, Scotti G: Recurrent acute transverse myelopathy associ-
138. Kojima E, Naito K, Iwai M, et al: Antiphospholipid syndrome complicated by thrombo- ated with anticardiolipin antibodies. AJNR Am J Neuroradiol 19:781–786, 1998.
sis of the superior mesenteric artery, co-existence of smooth muscle hyperplasia. Intern 172. Smyth AE, Bruce IN, McMillan SA, Bell AL: Transverse myelitis: A complication of
Med 36:528–531, 1997. systemic lupus erythematosus that is associated with the antiphospholipid syndrome.
139. Girolami A, Zanon E, Zanardi S, et al: Thromboembolic disease developing during oral Ulster Med J 65:91–94, 1996.
contraceptive therapy in young females with antiphospholipid antibodies. Blood Coagul 173. Mok CC, Lau CS, Chan EY, Wong RW: Acute transverse myelopathy in systemic lupus
Fibrinolysis 7:497–501, 1996. erythematosus: Clinical presentation, treatment, and outcome. J Rheumatol 25:467–
140. Montaruli B, Borchiellini A, Tamponi G, et al: Factor V Arg506—>Gln mutation in 473, 1998.
patients with antiphospholipid antibodies. Lupus 5:303–306, 1996. 174. Sugiyama Y, Yamamoto T: Characterization of serum anti-phospholipid antibodies in
141. Simantov R, Lo SK, Salmon JE, et al: Factor V Leiden increases the risk of thrombosis patients with multiple sclerosis. Tohoku J Exp Med 178:203–215, 1996.
in patients with antiphospholipid antibodies. Thromb Res 84:361–365, 1996. 175. Schwartz M, Rochas M, Weller B, et al: High association of anticardiolipin antibodies
142. Schutt M, Kluter H, Hagedorn GM, et al: Familial coexistence of primary antiphospho- with psychosis. J Clin Psychiatry 59:20–23, 1998.
lipid syndrome and factor V Leiden. Lupus 7:176–182, 1998. 176. Espinosa G, Bucciarelli S, Asherson RA, Cervera R: Morbidity and mortality in the
143. Brenner B, Vulfsons SL, Lanir N, Nahir M: Coexistence of familial antiphospholipid catastrophic antiphospholipid syndrome: Pathophysiology, causes of death, and prog-
syndrome and factor V Leiden: Impact on thrombotic diathesis. Br J Haematol 94:166– nostic factors. Semin Thromb Hemost 34:290–294, 2008.
167, 1996. 177. Erkan D, Cervera R, Asherson RA: Catastrophic antiphospholipid syndrome: Where do
144. Pengo V, Ruffatti A, Legnani C, et al: Incidence of a first thromboembolic event in we stand? Arthritis Rheum 48:3320–3327, 2003.
asymptomatic carriers of high-risk antiphospholipid antibody profile: A multicenter 178. Cervera R, Rodriguez-Pinto I, Colafrancesco S, et al: 14th International Congress on
prospective study. Blood 118:4714–4718, 2011. Antiphospholipid Antibodies Task Force report on catastrophic antiphospholipid syn-
145. Schulman S, Svenungsson E, Granqvist S: Anticardiolipin antibodies predict early drome. Autoimmun Rev 13:699–707, 2014.
recurrence of thromboembolism and death among patients with venous thromboem- 179. Bucciarelli S, Espinosa G, Cervera R, et al: Mortality in the catastrophic antiphos-
bolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Am pholipid syndrome: Causes of death and prognostic factors in a series of 250 patients.
J Med 104:332–338, 1998. Arthritis Rheum 54:2568–2576, 2006.
146. Finazzi G, Brancaccio V, Moia M, et al: Natural history and risk factors for thrombosis 180. Lockshin MD: Pregnancy loss and antiphospholipid antibodies. Lupus 7(Suppl 2):S86–
in 360 patients with antiphospholipid antibodies: A four-year prospective study from S89, 1998.
the Italian Registry. Am J Med 100:530–536, 1996. 181. Saha SP, Bhattacharjee N, Ganguli RP, et al: Prevalence and significance of antiphospho-
147. Gezer S: Antiphospholipid syndrome. Dis Mon 49:696–741, 2003. lipid antibodies in selected at-risk obstetrics cases: A comparative prospective study.
148. Gladd DA, Olech E: Antiphospholipid antibodies in rheumatoid arthritis: Identifying J Obstet Gynaecol 29:614–618, 2009.
the dominoes. Curr Rheumatol Rep 11:43–51, 2009. 182. Ruffatti A, Calligaro A, Hoxha A, et al: Laboratory and clinical features of pregnant
149. Fauchais AL, Lambert M, Launay D, et al: Antiphospholipid antibodies in primary women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res
Sjogren’s syndrome: Prevalence and clinical significance in a series of 74 patients. Lupus (Hoboken) 62:302–307, 2010.
13:245–248, 2004. 183. Rai R: Obstetric management of antiphospholipid syndrome. J Autoimmun 15:203–207,
150. Shoenfeld Y, Meroni PL: The beta-2-glycoprotein I and antiphospholipid antibodies. 2000.
Clin Exp Rheumatol 10:205–209, 1992. 184. Rai R, Regan L: Obstetric complications of antiphospholipid antibodies. Curr Opin
151. Yun YY, Yoh KA, Yang HI, et al: A case of Budd-Chiari syndrome with high antiphos- Obstet Gynecol 9:387–390, 1997.
pholipid antibody in a patient with systemic lupus erythematosus. Korean J Intern Med 185. Saha SP, Bhattacharjee N, Ganguli RP, et al: Prevalence and significance of anti-
11:82–86, 1996. phospholipid antibodies in selected at-risk obstetrics cases: A comparative prospective
152. Hofbauer LC, Spitzweg C, Heufelder AE: Graves’ disease associated with the primary study. J Obstet Gynaecol 29:614–618, 2009.
antiphospholipid syndrome. J Rheumatol 23:1435–1437, 1996. 186. Ruffatti A, Calligaro A, Hoxha A, et al: Laboratory and clinical features of pregnant
153. Chun WH, Bang D, Lee SK: Antiphospholipid syndrome associated with progressive women with antiphospholipid syndrome and neonatal outcome. Arthritis Care Res
systemic sclerosis. J Dermatol 23:347–351, 1996. (Hoboken) 62:302–307, 2010.
154. Frolow M, Jankowski M, Swadzba J, Musial J: Evan’s syndrome with antiphospholipid- 187. Ornstein MH, Rand JH: An association between refractory HELLP syndrome and
protein antibodies. Pol Merkur Lekarski 1:344–345, 1996. antiphospholipid antibodies during pregnancy; a report of 2 cases. J Rheumatol 21:
155. Yokoi K, Hosoi E, Akaike M, et al: Takayasu’s arteritis associated with antiphospholipid 1360–1364, 1994.
antibodies. Report of two cases. Angiology 47:315–319, 1996. 188. Neuwelt CM, Daikh DI, Linfoot JA, et al: Catastrophic antiphospholipid syndrome:
156. Dasgupta B, Almond MK, Tanqueray A: Polyarteritis nodosa and the antiphospholipid Response to repeated plasmapheresis over three years. Arthritis Rheum 40:1534–1539,
syndrome. Br J Rheumatol 36:1210–1212, 1997. 1997.
157. Cervera R, Boffa MC, Khamashta MA, Hughes GR: The Euro-Phospholipid project: 189. Ramsey-Goldman R, Kutzer JE, Kuller LH, et al: Pregnancy outcome and anti-cardio-
Epidemiology of the antiphospholipid syndrome in Europe. Lupus 18:889–893, 2009. lipin antibody in women with systemic lupus erythematosus. Am J Epidemiol 138:1057–
158. Bucciarelli S, Espinosa G, Cervera R: The CAPS Registry: Morbidity and mortality of 1069, 1993.
the catastrophic antiphospholipid syndrome. Lupus 18:905–912, 2009. 190. Chauleur C, Galanaud JP, Alonso S, et al: Observational study of pregnant women with
159. Urbanus RT, Siegerink B, Roest M, et al: Antiphospholipid antibodies and risk of myo- a previous spontaneous abortion before the 10th gestation week with and without anti-
cardial infarction and ischaemic stroke in young women in the RATIO study: A case- phospholipid antibodies. J Thromb Haemost 8:699–706, 2010.
control study. Lancet Neurol 8:998–1005, 2009. 191. Bergrem A, Jacobsen EM, Skjeldestad FE, et al: The association of antiphospholipid
160. Levine SR, Deegan MJ, Futrell N, Welch KM: Cerebrovascular and neurologic disease antibodies with pregnancy-related first time venous thrombosis—A population-based
associated with antiphospholipid antibodies: 48 cases. Neurology 40:1181–1189, 1990. case-control study. Thromb Res 125:e222–e227, 2010.
161. Weingarten K, Filippi C, Barbut D, Zimmerman RD: The neuroimaging features of the 192. Locatelli A, Patane L, Ghidini A, et al: Pathology findings in preterm placentas of
cardiolipin antibody syndrome. Clin Imaging 21:6–12, 1997. women with autoantibodies: A case-control study. J Matern Fetal Neonatal Med 11:
162. Carhuapoma JR, Mitsias P, Levine SR: Cerebral venous thrombosis and anticardiolipin 339–344, 2002.
antibodies. Stroke 28:2363–2369, 1997. 193. Salafia CM, Cowchock FS: Placental pathology and antiphospholipid antibodies: A
163. Deschiens MA, Conard J, Horellou MH, et al: Coagulation studies, factor V Leiden, and descriptive study. Am J Perinatol 14:435–441, 1997.
anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 27:1724– 194. Salafia CM, Parke AL: Placental pathology in systemic lupus erythematosus and phos-
1730, 1996. pholipid antibody syndrome. Rheum Dis Clin North Am 23:85–97, 1997.
164. Nagai S, Horie Y, Akai T, et al: Superior sagittal sinus thrombosis associated with pri- 195. Sauer R, Roussev R, Jeyendran RS, Coulam CB: Prevalence of antiphospholipid anti-
mary antiphospholipid syndrome—Case report. Neurol Med Chir (Tokyo) 38:34–39, bodies among women experiencing unexplained infertility and recurrent implantation
1998. failure. Fertil Steril 93:2441–2443, 2010.
165. Tanasescu R, Nicolau A, Caraiola S, et al: Antiphospholipid antibodies and migraine: A 196. de Jesus GR, Rodrigues G, de Jesus NR, Levy RA: Pregnancy morbidity in antiphospho-
retrospective study of 428 patients with inflammatory connective tissue diseases. Rom J lipid syndrome: What is the impact of treatment? Curr Rheumatol Rep 16:403, 2014.
Intern Med 45:355–363, 2007. 197. Practice Committee of American Society for Reproductive Medicine. Anti-phospho-
166. Ong MS, Kohane IS, Cai T, et al: Population-level evidence for an autoimmune etiology lipid antibodies do not affect IVF success. Fertil Steril 90(5 Suppl):S172–S173, 2008.
of epilepsy. JAMA Neurol 71:569–574, 2014. 198. Kriseman YL, Nash JW, Hsu S: Criteria for the diagnosis of antiphospholipid syndrome
167. Brey RL, Escalante A: Neurological manifestations of antiphospholipid antibody syn- in patients presenting with dermatologic symptoms. J Am Acad Dermatol 57:112–115,
drome. Lupus 7(Suppl 2):S67–S74, 1998. 2007.

Kaushansky_chapter 131_p2233-2252.indd 2248 9/18/15 5:10 PM